Live feed16:05:12·461dSECFilingvia QuantisnowInterpace Biosciences, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Costs Associated with Exit or Disposal ActivitiesByQuantisnow·Wall Street's wire, on your screen.IDXG· Interpace Biosciences, Inc.Health CareOriginal source
